select a format

Single User License
USD 350 INR 22747
Site License
USD 700 INR 45493
Corporate User License
USD 1050 INR 68240

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


Biotechnology in Asia-Pacific

Biotechnology in Asia-Pacific


  • Products Id :- OHME8009
  • |
  • Pages: 35
  • |
  • November 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts

Reasons To Buy

What was the size of the Asia-Pacific biotechnology market by value in 2016?

What will be the size of the Asia-Pacific biotechnology market in 2021?

What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Asia-Pacific's biotechnology market?

Key Highlights

The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The Asia-Pacific biotechnology market is expected to generate total revenues of $86.8bn in 2016, representing a compound annual growth rate (CAGR) of 6% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $47.2bn, equivalent to 54.4% of the market's overall value.

Japan continues to be the most valuable biotechnology in the Asia-Pacific region, leading to investment which will continue the strong recent performances of the industry. Biotechnology in Japan is unusually balanced; most countries biotech industry is heavily weighted in favor of medicine and healthcare.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Astellas Pharma Inc.

Merck & Co., Inc.

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Company Limited

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2012-16(e)

Figure 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2016(e)

Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2016(e)

Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2016-21

Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2016

Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2016

Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2016

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2016

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2016

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2016

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities

Table 1: Asia-Pacific biotechnology industry value: $ billion, 2012-16(e)

Table 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016(e)

Table 3: Asia-Pacific biotechnology industry geography segmentation: $ billion, 2016(e)

Table 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2016-21

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials ($)

Table 7: Astellas Pharma Inc.: key financials (YEN)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials ($)

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: Mitsubishi Tanabe Pharma Corporation: key facts

Table 13: Mitsubishi Tanabe Pharma Corporation: key financials ($)

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (YEN)

Table 15: Mitsubishi Tanabe Pharma Corporation: key financial ratios

Table 16: Takeda Pharmaceutical Company Limited: key facts

Table 17: Takeda Pharmaceutical Company Limited: key financials ($)

Table 18: Takeda Pharmaceutical Company Limited: key financials (YEN)

Table 19: Takeda Pharmaceutical Company Limited: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Astellas Pharma Inc. Merck & Co., Inc. Mitsubishi Tanabe Pharma Corporation Takeda Pharmaceutical Company Limited

Biotechnology, MarketLine, Asia-Pacific


Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com